Coherus Oncology
CHRS
CHRS
156 hedge funds and large institutions have $99.8M invested in Coherus Oncology in 2026 Q1 according to their latest regulatory filings, with 41 funds opening new positions, 46 increasing their positions, 37 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
3% less ownership
Funds ownership: 42.46% → 39.46% (-3%)
70% less call options, than puts
Call options by funds: $132K | Put options by funds: $436K
Holders
156
Holding in Top 10
1
Calls
$132K
Puts
$436K
Top Buyers
| 1 | +$6.09M | |
| 2 | +$4M | |
| 3 | +$3.19M | |
| 4 |
PBM
Propel Bio Management
Los Angeles,
California
|
+$2.52M |
| 5 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
+$1.54M |
Top Sellers
| 1 | -$1.49M | |
| 2 | -$1,000K | |
| 3 | -$619K | |
| 4 |
BlackRock
New York
|
-$351K |
| 5 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$286K |
